Primary nitinol stenting in femoropopliteal occlusive disease: A Meta-Analysis of randomized controlled trials

Journal of Endovascular Therapy

Volumn 19, Issue 5, 2012, Pages 585-595

  Acin, Francisco ^a   De Haro, Joaquin ^a,b   Bleda, Silvia ^a   Varela, Cesar ^a   Esparza, Leticia ^a  

^a HOSPITAL UNIVERSITARIO DE GETAFE   (Spain)

^b NONE   (Spain)

Author keywords

Balloon angioplasty; Femoropopliteal segment; Meta analysis; Mortality; Nitinol stent; Occlusion; Randomized controlled trials; Reintervention; Restenosis; Stenosis

Indexed keywords

EID: 84868349402     PISSN: 15266028     EISSN: 15451550     Source Type: Journal    
DOI: 10.1583/JEVT-12-3898R.1     Document Type: Article

References (29)

1. Dormandy JA, Rutherford RB. Management of peripheral arterial disease (PAD). TASC Working Group. TransAtlantic Inter-Society Consensus (TASC). J Vasc Surg. 2000;31:S1-S296.
2. Norgren L, Hiatt WR, Dormandy JA, et al. Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II). J Vasc Surg. 2007;45 Suppl S: S5-67.
3. Adam DJ, Beard JD, Cleveland T, et al; Basil Trial participants. Bypass versus angioplasty in severe ischaemia of the leg (BASIL): Multicentre, randomised controlled trial. Lancet. 2005;366:1925-1934.
4. Vroegindeweij D, Vos L, Tielbeek A, et al. Balloon angioplasty combined with primary stenting versus balloon angioplasty alone in femoropopliteal obstructions: A comparative randomized study. Cardiovasc Intervent Radiol. 1997;20:420-425.
5. Zdanowski Z, Troeng T, Norgren L. Outcome and influence of age after infrainguinal revascularization in critical limb ischaemia. The Swedish Vascular Registry. Eur J Vasc Endovasc Surg. 1998;16:137-141.
6. Grimm J, Müller-Hülsbeck S, Jahnke T, et al. Randomized study to compare PTA alone versus PTA with Palmaz stent placement for femoropopliteal lesions. J Vasc Interv Radiol. 2001;12:935-941.
7. Cejna M, Thurnher S, Illiasch H, et al. PTA versus Palmaz stent placement in femoropopliteal artery obstructions: A multicenter prospective randomized study. J Vasc Interv Radiol. 2001;12:23-31.
8. Hirsch AT, Haskal ZJ, Hertzer NR, et al. ACC/ AHA 2005 guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): Executive summary a collaborative report from the American Association for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Peripheral Arterial Disease) endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation; National Heart, Lung, and Blood Institute; Society for Vascular Nursing; TransAtlantic Inter-Society Consensus; and Vascular Disease Foundation. J Am Coll Cardiol. 2006;47:1239-1312.
9. Jadad AR, Moore RA, Carroll D, et al. Assessing the quality of reports of randomized clinical trials: Is blinding necessary? Control Clin Trials. 1996;17:1-12.
10. Schillinger M, Sabeti S, Loewe C, et al. Balloon angioplasty versus implantation of nitinol stents in the superficial femoral artery. N Engl J Med. 2006;354:1879-1888.
11. Krankenberg H, Schluter M, Steinkamp HJ, et al. Nitinol stent implantation versus percutaneous transluminal angioplasty in superficial femoral artery lesions up to 10 cm in length: The femoral artery stenting trial (FAST). Circulation. 2007;116:285-292.
12. Dick P, Wallner H, Sabeti S, et al. Balloon angioplasty versus stenting with nitinol stents in intermediate length superficial femoral artery lesions. Catheter Cardiovasc Interv. 2009; 74:1090-1095.
13. Laird JR, Katzen BT, Scheinert D, et al.; RESILIENT Investigators. Nitinol stent implantation versus balloon angioplasty for lesions in the superficial femoral artery and proximal popliteal artery: Twelve-month results from the RESILIENT randomized trial. Circ Cardiovasc Interv. 2010;3:267-276.
14. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7:177-188.
15. L'Abb́e K, Detsky A, O'Rourke K. Meta-analysis in clinical research. Ann Intern Med. 1987;107: 224-233.
16. Galbraith R. A note on graphical presentation if estimated odds ratios from several clinical trials. Stat Med. 1988;7:889-894.
17. Egger M, Smith GD, Phillips AN. Meta-analysis: Principles and procedures. BMJ. 1997;315: 1533-1537.
18. Begg CB, Mazumsdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics. 1994;50:1088-1101.
19. Egger M, Smith GD, Schneider M, et al. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315:629-634.
20. Muradin GS, Bosch TL, Stijnen T, et al. Balloon dilation and stent implantation for treatment of femoropopliteal arterial disease: Meta-analysis. Radiology. 2001;221:137-145.
21. Ansel GM, Botti CF, George BS, et al. Clinical results for training-phase roll-in patients in the Intracoil femoral popliteal stent trial. Catheter Cardiovasc Interv. 2002;56:443-449.
22. Greenberg D, Rosenfield K, Garćia L, et al. Inhospital cost of self-expanding nitinol stent implantation versus ballon angioplasty in the femoropopliteal artery (The Vascucoil Trial). J Vasc Interv Radiol. 2004;15:1065-1069.
23. Bosiers M, Torsello G, Gissler HM, et al. Nitinol stent implantation in long superficial femoral artery lesions: 12-month results of the DURABILITY I study. J Endovasc Ther. 2009;16:261-269.
24. Soga Y, Iida O, Hirano K, et al. Mid-term clinical outcome and predictors of vessel patency after femoropopliteal stenting with self-expandable nitinol stent. J Vasc Surg. 2010;52:608-415.
25. Scheinert D, Scheinert S, Sax J, et al. Prevalence and clinical impact of stent fractures after femoropopliteal stenting. J Am Coll Cardiol. 2005;45:312-315.
26. Mwipatayi BP, Hockings A, Hofmann M, et al. Balloon angioplasty compared with stenting for treatment of femoropopliteal occlusive disease: A meta-analysis. J Vasc Surg. 2008; 47:461-469.
27. He N, Wang Y, et al. Percutaneous transluminal angioplasty (PTA) alone versus PTA with balloon-expandable stent placement for short-segment femoropopliteal artery disease: A metaanalysis of randomized trials. J Vasc Interv Radiol. 2008;19:499-503.
28. Twine CP, Coulson J, Shandall A, et al. Angioplasty versus stenting for superficial femoral artery lesions. Cochrane Database Syst Rev. 2009;(2):CD006767.
29. Kasapis C, Henke PK, Chetcuti SJ, et al. Routine stent implantation vs. percutaneous transluminal angioplasty in femoropopliteal artery disease: A meta-analysis of randomized controlled trials. Eur Heart J. 2009;30:44-55.